Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1918 1
1946 2
1947 1
1948 2
1949 1
1950 1
1951 3
1952 1
1953 1
1954 2
1955 2
1956 1
1957 4
1958 1
1959 2
1960 2
1961 3
1962 11
1963 9
1964 11
1965 14
1966 24
1967 22
1968 22
1969 28
1970 25
1971 29
1972 24
1973 30
1974 26
1975 37
1976 34
1977 40
1978 50
1979 44
1980 47
1981 49
1982 63
1983 58
1984 53
1985 73
1986 64
1987 57
1988 71
1989 106
1990 104
1991 105
1992 96
1993 118
1994 127
1995 124
1996 138
1997 151
1998 165
1999 151
2000 175
2001 178
2002 175
2003 176
2004 210
2005 214
2006 204
2007 242
2008 237
2009 279
2010 304
2011 330
2012 386
2013 368
2014 377
2015 385
2016 425
2017 474
2018 475
2019 459
2020 549
2021 626
2022 328
Text availability
Article attribute
Article type
Publication date

Search Results

9,038 results
Results by year
Filters applied: . Clear all
Page 1
CAR T cells produced in vivo to treat cardiac injury.
Rurik JG, Tombácz I, Yadegari A, Méndez Fernández PO, Shewale SV, Li L, Kimura T, Soliman OY, Papp TE, Tam YK, Mui BL, Albelda SM, Puré E, June CH, Aghajanian H, Weissman D, Parhiz H, Epstein JA. Rurik JG, et al. Among authors: kimura t. Science. 2022 Jan 7;375(6576):91-96. doi: 10.1126/science.abm0594. Epub 2022 Jan 6. Science. 2022. PMID: 34990237
An RNA aptamer restores defective bone growth in FGFR3-related skeletal dysplasia in mice.
Kimura T, Bosakova M, Nonaka Y, Hruba E, Yasuda K, Futakawa S, Kubota T, Fafilek B, Gregor T, Abraham SP, Gomolkova R, Belaskova S, Pesl M, Csukasi F, Duran I, Fujiwara M, Kavkova M, Zikmund T, Kaiser J, Buchtova M, Krakow D, Nakamura Y, Ozono K, Krejci P. Kimura T, et al. Sci Transl Med. 2021 May 5;13(592):eaba4226. doi: 10.1126/scitranslmed.aba4226. Sci Transl Med. 2021. PMID: 33952673
P2Y12 inhibitor monotherapy or dual antiplatelet therapy after coronary revascularisation: individual patient level meta-analysis of randomised controlled trials.
Valgimigli M, Gragnano F, Branca M, Franzone A, Baber U, Jang Y, Kimura T, Hahn JY, Zhao Q, Windecker S, Gibson CM, Kim BK, Watanabe H, Song YB, Zhu Y, Vranckx P, Mehta S, Hong SJ, Ando K, Gwon HC, Serruys PW, Dangas GD, McFadden EP, Angiolillo DJ, Heg D, Jüni P, Mehran R. Valgimigli M, et al. Among authors: kimura t. BMJ. 2021 Jun 16;373:n1332. doi: 10.1136/bmj.n1332. BMJ. 2021. PMID: 34135011 Free PMC article.
Exosomal CD47 Plays an Essential Role in Immune Evasion in Ovarian Cancer.
Shimizu A, Sawada K, Kobayashi M, Yamamoto M, Yagi T, Kinose Y, Kodama M, Hashimoto K, Kimura T. Shimizu A, et al. Among authors: kimura t. Mol Cancer Res. 2021 Sep;19(9):1583-1595. doi: 10.1158/1541-7786.MCR-20-0956. Epub 2021 May 20. Mol Cancer Res. 2021. PMID: 34016744
Bleeding avoidance strategies in percutaneous coronary intervention.
Capodanno D, Bhatt DL, Gibson CM, James S, Kimura T, Mehran R, Rao SV, Steg PG, Urban P, Valgimigli M, Windecker S, Angiolillo DJ. Capodanno D, et al. Among authors: kimura t. Nat Rev Cardiol. 2022 Feb;19(2):117-132. doi: 10.1038/s41569-021-00598-1. Epub 2021 Aug 23. Nat Rev Cardiol. 2022. PMID: 34426673 Review.
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA).
Hamanishi J, Takeshima N, Katsumata N, Ushijima K, Kimura T, Takeuchi S, Matsumoto K, Ito K, Mandai M, Nakai H, Sakuragi N, Watari H, Takahashi N, Kato H, Hasegawa K, Yonemori K, Mizuno M, Takehara K, Niikura H, Sawasaki T, Nakao S, Saito T, Enomoto T, Nagase S, Suzuki N, Matsumoto T, Kondo E, Sonoda K, Aihara S, Aoki Y, Okamoto A, Takano H, Kobayashi H, Kato H, Terai Y, Takazawa A, Takahashi Y, Namba Y, Aoki D, Fujiwara K, Sugiyama T, Konishi I. Hamanishi J, et al. Among authors: kimura t. J Clin Oncol. 2021 Nov 20;39(33):3671-3681. doi: 10.1200/JCO.21.00334. Epub 2021 Sep 2. J Clin Oncol. 2021. PMID: 34473544 Clinical Trial.
9,038 results